The use of alpha blockers causes an increased incidence of IFIS and, with it, an increased morbidity during routine cataract surgery. We are urging a new PPP for these patients: If a urologist is considering starting a patient on an alpha blocker to treat urinary symptoms, a baseline exam from the ophthalmologist should be obtained prior to the start of treatment. If a cataract is detected, it should be removed prior to the initiation of alpha antagonist therapy. This would go a long way toward minimizing the morbidity in these patients.
No comments yet.join the discussion
louis morrone, Elizabeth, NJ, United States4 years ago
Jeffrey R. Van Inwegen, MD, Elizabeth, NJ, United States4 years ago
jon Weston, Roseburg, OR, United States4 years ago
There are no highlights yet.